SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-23-009425
Filing Date
2023-05-11
Accepted
2023-05-11 17:00:26
Documents
63
Period of Report
2023-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q gpcr-20230331x10q.htm   iXBRL 10-Q 2318958
2 EX-4.5 gpcr-20230331xex4d5.htm EX-4.5 11496
3 EX-10.1 gpcr-20230331xex10d1.htm EX-10.1 75266
4 EX-31.1 gpcr-20230331xex31d1.htm EX-31.1 15749
5 EX-31.2 gpcr-20230331xex31d2.htm EX-31.2 16033
6 EX-32.1 gpcr-20230331xex32d1.htm EX-32.1 9943
7 EX-32.2 gpcr-20230331xex32d2.htm EX-32.2 10230
8 GRAPHIC gpcr-20230331x10q001.jpg GRAPHIC 52366
  Complete submission text file 0001558370-23-009425.txt   7683261

Data Files

Seq Description Document Type Size
9 EX-101.SCH gpcr-20230331.xsd EX-101.SCH 37606
10 EX-101.CAL gpcr-20230331_cal.xml EX-101.CAL 40762
11 EX-101.DEF gpcr-20230331_def.xml EX-101.DEF 165918
12 EX-101.LAB gpcr-20230331_lab.xml EX-101.LAB 376691
13 EX-101.PRE gpcr-20230331_pre.xml EX-101.PRE 290710
57 EXTRACTED XBRL INSTANCE DOCUMENT gpcr-20230331x10q_htm.xml XML 1253283
Mailing Address 611 GATEWAY BLVD SUITE 223 SOUTH SAN FRANCISCO CA 94080
Business Address 611 GATEWAY BLVD SUITE 223 SOUTH SAN FRANCISCO CA 94080 (628) 229-9277
Structure Therapeutics Inc. (Filer) CIK: 0001888886 (see all company filings)

IRS No.: 981480821 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-41608 | Film No.: 23911989
SIC: 2834 Pharmaceutical Preparations